Global RNA Biopesticide Supply, Demand and Key Producers, 2026-2032

November 2026 | 109 pages | ID: GE89B3417FF0EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global RNA Biopesticide market size is expected to reach $ 353 million by 2032, rising at a market growth of 18.2% CAGR during the forecast period (2026-2032).

RNA Biopesticide refers to crop-protection products and pesticidal traits whose biological activity is primarily based on RNA molecules, particularly double-stranded RNA (dsRNA), which induce RNA interference (RNAi) and sequence-specific gene silencing in target pests or pathogens. The market is primarily divided into PIP and Non-PIP pathways. PIP products are plant-incorporated protectants in which genetically engineered crops express pesticidal RNA within plant tissues and are commercialized mainly through seed and trait systems. Non-PIP products use externally manufactured RNA active ingredients that are formulated for foliar spray, irrigation, root-zone application, seed treatment, or other targeted delivery routes. Core technical elements include target-sequence design, RNA production and purification, formulation, delivery, environmental stabilization, target uptake, and quality control. By Application, the market is divided into Farmland, Orchard, and Other applications, covering major field crops, potatoes, fruit crops, tobacco, protected horticulture, and other specialty crops.

Key Findings

PIP remains the dominant commercial pathway, supported mainly by established RNAi traits in major field crops

Non-PIP is emerging as the principal incremental growth direction as externally applied RNA products broaden their crop and target coverage

Farmland remains the primary commercial application, while orchard and specialty-crop applications are moving toward broader commercialization

Commercial maturity remains highly uneven by region, with established markets coexisting with regulatory-entry and pre-commercial regions

The competitive landscape is concentrated in realized revenue but substantially broader in technology development and product pipelines

Market Trends

The RNA Biopesticide industry is transitioning from a market led primarily by RNAi-based PIP traits toward a more diversified structure in which externally applied Non-PIP products play an increasingly important role. Commercial PIP technologies remain concentrated in major field crops, especially corn, while Non-PIP development is expanding into insect control, fungal disease management, plant-virus control, nematodes, and other targeted applications. Advances in biological and cell-free RNA manufacturing, formulation stability, encapsulation, controlled release, uptake enhancement, and environmental protection are improving the practical feasibility of externally applied RNA products. Product development is also moving from narrowly defined crop-pest combinations toward broader portfolios covering potatoes, grapes, tobacco, horticultural crops, and other high-value applications. The long-term direction is toward highly selective crop-protection tools that can be integrated with conventional chemical and biological products in integrated pest management and resistance-management programs.

Market Dynamics

Drivers

Market development is being driven by increasing resistance to established pesticide modes of action, growing demand for selective crop-protection solutions, stricter residue and environmental expectations, and continued advances in RNA manufacturing and delivery technologies. Commercial deployment of RNAi traits has demonstrated the feasibility of RNA-based crop protection at agricultural scale, while the emergence of registered externally applied products is establishing an additional commercialization pathway. Regulatory progress in major agricultural markets and increasing participation by established seed and crop-protection companies are also supporting the transition from research-oriented development toward broader commercial adoption.

Restraints

Commercialization remains constrained by formulation stability and field-performance limitations, particularly RNA degradation caused by ultraviolet exposure, rainfall, temperature, and biological activity in the environment. For Non-PIP products, manufacturing cost, application rate, delivery efficiency, and cost per hectare remain important commercial considerations. PIP products depend on genetically engineered seed and trait systems, making adoption closely linked to biotechnology regulation and seed-market acceptance. The still-limited number of registered RNA products and relatively narrow crop-target combinations also restrict near-term market breadth.

Opportunities

The most significant market opportunities are expected to come from the expansion of Non-PIP products into applications that are difficult to address through seed-based PIP systems. Potential growth areas include fungal diseases, plant viruses, difficult-to-control insect pests, nematodes, high-value fruit crops, protected horticulture, and specialty crops. Orchard and vineyard systems are particularly attractive because of high crop value, intensive crop-protection requirements, and strong demand for selective and low-residue solutions. Additional opportunities are also emerging in regions where regulatory pathways are becoming clearer and local field-validation programs are progressing toward registration and commercialization.

Challenges

The industry must demonstrate consistent field efficacy across different crops, climates, application systems, and pest populations while maintaining economically competitive treatment costs. Developers also face lengthy regulatory processes, extensive environmental and non-target testing requirements, scale-up risks in RNA manufacturing, formulation complexity, and the need to establish effective technical-support and distribution systems. Long-term commercialization will also depend on resistance-management stewardship, accurate target selection, intellectual-property protection, manufacturing reliability, and coordination among technology developers, seed companies, crop-protection companies, regulators, distributors, and growers.

Industry Chain Analysis

The RNA Biopesticide industry chain differs significantly between PIP and Non-PIP products. For PIP, upstream activities include target discovery, gene-sequence selection, genetic construct development, crop transformation, breeding, trait integration, seed multiplication, and regulatory testing. For Non-PIP, the upstream chain is more manufacturing-intensive and includes RNA sequence design, biological or cell-free synthesis, purification, analytical testing, formulation carriers, adjuvants, encapsulation materials, stabilizers, and delivery technologies. Technical value is increasingly concentrated in low-cost RNA production, environmental stability, target uptake, and effective delivery under field conditions.

Midstream activities include trait commercialization and seed production for PIP products, and RNA active-ingredient manufacturing, formulation, filling, packaging, and quality assurance for Non-PIP products. Downstream participants include seed and trait companies, crop-protection formulators, agricultural distributors, retailers, professional application services, grower cooperatives, and commercial growers. PIP economics are mainly linked to the value attributable to the RNAi pesticidal trait within a commercial seed system, while Non-PIP profitability depends more directly on RNA production cost, dose per hectare, formulation cost, manufacturing utilization, registered crop coverage, and channel efficiency. As the industry matures, value creation is expected to shift increasingly toward proprietary sequence design, formulation and delivery technologies, regulatory assets, and commercially validated crop-target portfolios.

Segment Insights

PIP remains the dominant product pathway because of established commercialization in major field crops, mature seed-distribution systems, and the scalability of trait-based deployment. However, its relative dominance is expected to moderate as Non-PIP products expand into additional crops, pests, and diseases. Non-PIP has stronger structural flexibility because externally applied RNA products can be adapted to multiple crops and target organisms without relying on genetically engineered seed systems. Improvements in RNA production economics, formulation stability, and delivery efficiency are expected to strengthen its commercial relevance over time.

By Application, Farmland remains the principal commercial segment, supported by RNAi traits in field crops and the commercialization of externally applied RNA products in selected broadacre applications. Orchard applications are developing around high-value fruit crops, fungal disease control, and other targeted uses where selective and low-residue solutions are particularly attractive. Other applications include tobacco, greenhouse and protected horticulture, nurseries, flowers, and specialty crops, where controlled production environments and high crop value can support adoption of targeted Non-PIP technologies.

Downstream Market Opportunities

Downstream demand is expected to broaden from large-scale field-crop production toward higher-value and more specialized crop-protection systems. Field crops will remain the principal commercial foundation because of established RNAi traits and extensive planted areas, while potatoes and other crops facing insecticide-resistance pressure provide opportunities for externally applied RNA insecticides. Orchards, vineyards, protected horticulture, tobacco, vegetables, and other specialty crops offer attractive opportunities where growers place greater value on residue management, target specificity, and novel modes of action. The strongest commercial opportunities are likely to emerge where RNA products can be integrated into existing application practices and provide clear resistance-management, efficacy, or residue advantages.

Regional Insights

Regional commercialization remains highly uneven. North America and Latin America currently represent the principal commercial markets, supported largely by established RNAi crop traits, while North America also has the most diversified commercialization structure because both PIP and externally applied Non-PIP products have entered agricultural use. Latin America remains strongly supported by large-scale field-crop production and PIP adoption, while externally applied RNA products are creating additional development opportunities in high-value and export-oriented crops.

Europe remains at an early commercialization and regulatory-expansion stage, with Non-PIP products expected to play a leading role in future adoption. China has entered initial commercialization and is developing capabilities in RNA manufacturing, formulation, and domestic product development. Asia-Pacific excluding China remains mainly in R&D and pre-commercial development, with Australia and Japan important in technology development and other Asian agricultural markets providing longer-term application potential. The Middle East and Africa remain earlier-stage markets, with potential concentrated in high-value horticulture, protected agriculture, and other specialized crop-protection applications.

Competitive Landscape Analysis

The RNA Biopesticide market is highly concentrated in realized commercial revenue but considerably more diverse in technology development and product pipelines. Bayer has a strong commercial position in PIP through established RNAi corn traits, while Corteva is expanding its presence through next-generation corn trait systems. GreenLight Biosciences represents one of the most advanced commercial participants in externally applied Non-PIP RNA biopesticides. Other companies, including RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, and Xiaomo Biotech, are positioned across RNA manufacturing, microbial or yeast-based delivery, formulation platforms, field-stage products, registration programs, and early commercialization. Competitive differentiation is increasingly shifting from ownership of individual RNAi traits toward integrated capabilities in low-cost RNA manufacturing, formulation and delivery, regulatory execution, target-specific product development, manufacturing scale-up, and access to seed or crop-protection distribution channels.

Report Scope

This report studies the global RNA Biopesticide demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for RNA Biopesticide, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Biopesticide that contribute to its increasing demand across many markets.

Highlights and key features of the study

  • Global RNA Biopesticide total market, 2021-2032, (USD Million)
  • Global RNA Biopesticide total market by region & country, CAGR, 2021-2032, (USD Million)
  • U.S. VS China: RNA Biopesticide total market, key domestic companies, and share, (USD Million)
  • Global RNA Biopesticide revenue by player, revenue and market share 2021-2026, (USD Million)
  • Global RNA Biopesticide total market by Type, CAGR, 2021-2032, (USD Million)
  • Global RNA Biopesticide total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global RNA Biopesticide market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Corteva, GreenLight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world RNA Biopesticide market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global RNA Biopesticide Market, By Region:

  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World

Market Segmentation

Global RNA Biopesticide Market, Segmentation by Type:

  • PIP
  • Non-PIP

Global RNA Biopesticide Market, Segmentation by Target Organism:

  • Insect Pests
  • Nematodes and Mites
  • Pathogens
  • Other

Global RNA Biopesticide Market, Segmentation by Crop:

  • Potatoes
  • Corn
  • Other

Global RNA Biopesticide Market, Segmentation by Application:

  • Farmland
  • Orchard
  • Other

Companies Profiled:

  • Bayer
  • Corteva
  • GreenLight Biosciences
  • RNAissance Ag
  • Pebble Labs
  • Renaissance BioScience
  • AgroSpheres
  • Silicon Gene
  • Shanghai Plant Science Biotechnology
  • Xiaomo Biotech

Key Questions Answered

1. How big is the global RNA Biopesticide market?
2. What is the demand of the global RNA Biopesticide market?
3. What is the year over year growth of the global RNA Biopesticide market?
4. What is the total value of the global RNA Biopesticide market?
5. Who are the Major Players in the global RNA Biopesticide market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 RNA Biopesticide Introduction
1.2 World RNA Biopesticide Market Size & Forecast (2021 & 2025 & 2032)
1.3 World RNA Biopesticide Total Market by Region (by Headquarter Location)
  1.3.1 World RNA Biopesticide Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.3 China Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.4 Europe Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.5 Japan Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.6 South Korea Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.7 ASEAN Based Company RNA Biopesticide Revenue (2021-2032)
  1.3.8 India Based Company RNA Biopesticide Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 RNA Biopesticide Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World RNA Biopesticide Consumption Value (2021-2032)
2.2 World RNA Biopesticide Consumption Value by Region
  2.2.1 World RNA Biopesticide Consumption Value by Region (2021-2026)
  2.2.2 World RNA Biopesticide Consumption Value Forecast by Region (2027-2032)
2.3 United States RNA Biopesticide Consumption Value (2021-2032)
2.4 China RNA Biopesticide Consumption Value (2021-2032)
2.5 Europe RNA Biopesticide Consumption Value (2021-2032)
2.6 Japan RNA Biopesticide Consumption Value (2021-2032)
2.7 South Korea RNA Biopesticide Consumption Value (2021-2032)
2.8 ASEAN RNA Biopesticide Consumption Value (2021-2032)
2.9 India RNA Biopesticide Consumption Value (2021-2032)

3 WORLD RNA BIOPESTICIDE COMPANIES COMPETITIVE ANALYSIS

3.1 World RNA Biopesticide Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global RNA Biopesticide Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for RNA Biopesticide in 2025
  3.2.3 Global Concentration Ratios (CR8) for RNA Biopesticide in 2025
3.3 RNA Biopesticide Company Evaluation Quadrant
3.4 RNA Biopesticide Market: Overall Company Footprint Analysis
  3.4.1 RNA Biopesticide Market: Region Footprint
  3.4.2 RNA Biopesticide Market: Company Product Type Footprint
  3.4.3 RNA Biopesticide Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: RNA Biopesticide Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: RNA Biopesticide Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: RNA Biopesticide Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: RNA Biopesticide Consumption Value Comparison
  4.2.1 United States VS China: RNA Biopesticide Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: RNA Biopesticide Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based RNA Biopesticide Companies and Market Share, 2021-2026
  4.3.1 United States Based RNA Biopesticide Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies RNA Biopesticide Revenue, (2021-2026)
4.4 China Based Companies RNA Biopesticide Revenue and Market Share, 2021-2026
  4.4.1 China Based RNA Biopesticide Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies RNA Biopesticide Revenue, (2021-2026)
4.5 Rest of World Based RNA Biopesticide Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based RNA Biopesticide Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies RNA Biopesticide Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World RNA Biopesticide Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 PIP
  5.2.2 Non-PIP
5.3 Market Segment by Type
  5.3.1 World RNA Biopesticide Market Size by Type (2021-2026)
  5.3.2 World RNA Biopesticide Market Size by Type (2027-2032)
  5.3.3 World RNA Biopesticide Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY TARGET ORGANISM

6.1 World RNA Biopesticide Market Size Overview by Target Organism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Organism
  6.2.1 Insect Pests
  6.2.2 Nematodes and Mites
  6.2.3 Pathogens
  6.2.4 Other
6.3 Market Segment by Target Organism
  6.3.1 World RNA Biopesticide Market Size by Target Organism (2021-2026)
  6.3.2 World RNA Biopesticide Market Size by Target Organism (2027-2032)
  6.3.3 World RNA Biopesticide Market Size Market Share by Target Organism (2027-2032)

7 MARKET ANALYSIS BY CROP

7.1 World RNA Biopesticide Market Size Overview by Crop: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Crop
  7.2.1 Potatoes
  7.2.2 Corn
  7.2.3 Other
7.3 Market Segment by Crop
  7.3.1 World RNA Biopesticide Market Size by Crop (2021-2026)
  7.3.2 World RNA Biopesticide Market Size by Crop (2027-2032)
  7.3.3 World RNA Biopesticide Market Size Market Share by Crop (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World RNA Biopesticide Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Farmland
  8.2.2 Orchard
  8.2.3 Other
8.3 Market Segment by Application
  8.3.1 World RNA Biopesticide Market Size by Application (2021-2026)
  8.3.2 World RNA Biopesticide Market Size by Application (2027-2032)
  8.3.3 World RNA Biopesticide Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 Bayer
  9.1.1 Bayer Details
  9.1.2 Bayer Major Business
  9.1.3 Bayer RNA Biopesticide Product and Services
  9.1.4 Bayer RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 Bayer Recent Developments/Updates
  9.1.6 Bayer Competitive Strengths & Weaknesses
9.2 Corteva
  9.2.1 Corteva Details
  9.2.2 Corteva Major Business
  9.2.3 Corteva RNA Biopesticide Product and Services
  9.2.4 Corteva RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 Corteva Recent Developments/Updates
  9.2.6 Corteva Competitive Strengths & Weaknesses
9.3 GreenLight Biosciences
  9.3.1 GreenLight Biosciences Details
  9.3.2 GreenLight Biosciences Major Business
  9.3.3 GreenLight Biosciences RNA Biopesticide Product and Services
  9.3.4 GreenLight Biosciences RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 GreenLight Biosciences Recent Developments/Updates
  9.3.6 GreenLight Biosciences Competitive Strengths & Weaknesses
9.4 RNAissance Ag
  9.4.1 RNAissance Ag Details
  9.4.2 RNAissance Ag Major Business
  9.4.3 RNAissance Ag RNA Biopesticide Product and Services
  9.4.4 RNAissance Ag RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 RNAissance Ag Recent Developments/Updates
  9.4.6 RNAissance Ag Competitive Strengths & Weaknesses
9.5 Pebble Labs
  9.5.1 Pebble Labs Details
  9.5.2 Pebble Labs Major Business
  9.5.3 Pebble Labs RNA Biopesticide Product and Services
  9.5.4 Pebble Labs RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Pebble Labs Recent Developments/Updates
  9.5.6 Pebble Labs Competitive Strengths & Weaknesses
9.6 Renaissance BioScience
  9.6.1 Renaissance BioScience Details
  9.6.2 Renaissance BioScience Major Business
  9.6.3 Renaissance BioScience RNA Biopesticide Product and Services
  9.6.4 Renaissance BioScience RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 Renaissance BioScience Recent Developments/Updates
  9.6.6 Renaissance BioScience Competitive Strengths & Weaknesses
9.7 AgroSpheres
  9.7.1 AgroSpheres Details
  9.7.2 AgroSpheres Major Business
  9.7.3 AgroSpheres RNA Biopesticide Product and Services
  9.7.4 AgroSpheres RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 AgroSpheres Recent Developments/Updates
  9.7.6 AgroSpheres Competitive Strengths & Weaknesses
9.8 Silicon Gene
  9.8.1 Silicon Gene Details
  9.8.2 Silicon Gene Major Business
  9.8.3 Silicon Gene RNA Biopesticide Product and Services
  9.8.4 Silicon Gene RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 Silicon Gene Recent Developments/Updates
  9.8.6 Silicon Gene Competitive Strengths & Weaknesses
9.9 Shanghai Plant Science Biotechnology
  9.9.1 Shanghai Plant Science Biotechnology Details
  9.9.2 Shanghai Plant Science Biotechnology Major Business
  9.9.3 Shanghai Plant Science Biotechnology RNA Biopesticide Product and Services
  9.9.4 Shanghai Plant Science Biotechnology RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 Shanghai Plant Science Biotechnology Recent Developments/Updates
  9.9.6 Shanghai Plant Science Biotechnology Competitive Strengths & Weaknesses
9.10 Xiaomo Biotech
  9.10.1 Xiaomo Biotech Details
  9.10.2 Xiaomo Biotech Major Business
  9.10.3 Xiaomo Biotech RNA Biopesticide Product and Services
  9.10.4 Xiaomo Biotech RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 Xiaomo Biotech Recent Developments/Updates
  9.10.6 Xiaomo Biotech Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 RNA Biopesticide Industry Chain
10.2 RNA Biopesticide Upstream Analysis
10.3 RNA Biopesticide Midstream Analysis
10.4 RNA Biopesticide Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. World RNA Biopesticide Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World RNA Biopesticide Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World RNA Biopesticide Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World RNA Biopesticide Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World RNA Biopesticide Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World RNA Biopesticide Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World RNA Biopesticide Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World RNA Biopesticide Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World RNA Biopesticide Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key RNA Biopesticide Players in 2025
Table 12. World RNA Biopesticide Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global RNA Biopesticide Company Evaluation Quadrant
Table 14. Head Office of Key RNA Biopesticide Players
Table 15. RNA Biopesticide Market: Company Product Type Footprint
Table 16. RNA Biopesticide Market: Company Product Application Footprint
Table 17. RNA Biopesticide Mergers & Acquisitions Activity
Table 18. United States VS China RNA Biopesticide Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China RNA Biopesticide Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based RNA Biopesticide Companies, Headquarters (States, Country)
Table 21. United States Based Companies RNA Biopesticide Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies RNA Biopesticide Revenue Market Share (2021-2026)
Table 23. China Based RNA Biopesticide Companies, Headquarters (Province, Country)
Table 24. China Based Companies RNA Biopesticide Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies RNA Biopesticide Revenue Market Share (2021-2026)
Table 26. Rest of World Based RNA Biopesticide Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies RNA Biopesticide Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies RNA Biopesticide Revenue Market Share (2021-2026)
Table 29. World RNA Biopesticide Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World RNA Biopesticide Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World RNA Biopesticide Market Size by Type (2027-2032) & (USD Million)
Table 32. World RNA Biopesticide Market Size by Target Organism, (USD Million), 2021 & 2025 & 2032
Table 33. World RNA Biopesticide Market Size Value by Target Organism (2021-2026) & (USD Million)
Table 34. World RNA Biopesticide Market Size by Target Organism (2027-2032) & (USD Million)
Table 35. World RNA Biopesticide Market Size by Crop, (USD Million), 2021 & 2025 & 2032
Table 36. World RNA Biopesticide Market Size Value by Crop (2021-2026) & (USD Million)
Table 37. World RNA Biopesticide Market Size by Crop (2027-2032) & (USD Million)
Table 38. World RNA Biopesticide Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World RNA Biopesticide Market Size by Application (2021-2026) & (USD Million)
Table 40. World RNA Biopesticide Market Size by Application (2027-2032) & (USD Million)
Table 41. Bayer Basic Information, Manufacturing Base and Competitors
Table 42. Bayer Major Business
Table 43. Bayer RNA Biopesticide Product and Services
Table 44. Bayer RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bayer Recent Developments/Updates
Table 46. Bayer Competitive Strengths & Weaknesses
Table 47. Corteva Basic Information, Manufacturing Base and Competitors
Table 48. Corteva Major Business
Table 49. Corteva RNA Biopesticide Product and Services
Table 50. Corteva RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Corteva Recent Developments/Updates
Table 52. Corteva Competitive Strengths & Weaknesses
Table 53. GreenLight Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. GreenLight Biosciences Major Business
Table 55. GreenLight Biosciences RNA Biopesticide Product and Services
Table 56. GreenLight Biosciences RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GreenLight Biosciences Recent Developments/Updates
Table 58. GreenLight Biosciences Competitive Strengths & Weaknesses
Table 59. RNAissance Ag Basic Information, Manufacturing Base and Competitors
Table 60. RNAissance Ag Major Business
Table 61. RNAissance Ag RNA Biopesticide Product and Services
Table 62. RNAissance Ag RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. RNAissance Ag Recent Developments/Updates
Table 64. RNAissance Ag Competitive Strengths & Weaknesses
Table 65. Pebble Labs Basic Information, Manufacturing Base and Competitors
Table 66. Pebble Labs Major Business
Table 67. Pebble Labs RNA Biopesticide Product and Services
Table 68. Pebble Labs RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Pebble Labs Recent Developments/Updates
Table 70. Pebble Labs Competitive Strengths & Weaknesses
Table 71. Renaissance BioScience Basic Information, Manufacturing Base and Competitors
Table 72. Renaissance BioScience Major Business
Table 73. Renaissance BioScience RNA Biopesticide Product and Services
Table 74. Renaissance BioScience RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Renaissance BioScience Recent Developments/Updates
Table 76. Renaissance BioScience Competitive Strengths & Weaknesses
Table 77. AgroSpheres Basic Information, Manufacturing Base and Competitors
Table 78. AgroSpheres Major Business
Table 79. AgroSpheres RNA Biopesticide Product and Services
Table 80. AgroSpheres RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AgroSpheres Recent Developments/Updates
Table 82. AgroSpheres Competitive Strengths & Weaknesses
Table 83. Silicon Gene Basic Information, Manufacturing Base and Competitors
Table 84. Silicon Gene Major Business
Table 85. Silicon Gene RNA Biopesticide Product and Services
Table 86. Silicon Gene RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Silicon Gene Recent Developments/Updates
Table 88. Silicon Gene Competitive Strengths & Weaknesses
Table 89. Shanghai Plant Science Biotechnology Basic Information, Manufacturing Base and Competitors
Table 90. Shanghai Plant Science Biotechnology Major Business
Table 91. Shanghai Plant Science Biotechnology RNA Biopesticide Product and Services
Table 92. Shanghai Plant Science Biotechnology RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Shanghai Plant Science Biotechnology Recent Developments/Updates
Table 94. Shanghai Plant Science Biotechnology Competitive Strengths & Weaknesses
Table 95. Xiaomo Biotech Basic Information, Manufacturing Base and Competitors
Table 96. Xiaomo Biotech Major Business
Table 97. Xiaomo Biotech RNA Biopesticide Product and Services
Table 98. Xiaomo Biotech RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Xiaomo Biotech Recent Developments/Updates
Table 100. Xiaomo Biotech Competitive Strengths & Weaknesses
Table 101. Global Key Players of RNA Biopesticide Upstream (Raw Materials)
Table 102. Global RNA Biopesticide Typical Customers

LIST OF FIGURES

Figure 1. RNA Biopesticide Picture
Figure 2. World RNA Biopesticide Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World RNA Biopesticide Total Revenue (2021-2032) & (USD Million)
Figure 4. World RNA Biopesticide Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World RNA Biopesticide Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company RNA Biopesticide Revenue (2021-2032) & (USD Million)
Figure 13. RNA Biopesticide Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 16. World RNA Biopesticide Consumption Value Market Share by Region (2021-2032)
Figure 17. United States RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 18. China RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 23. India RNA Biopesticide Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of RNA Biopesticide by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Biopesticide Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Biopesticide Markets in 2025
Figure 27. United States VS China: RNA Biopesticide Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: RNA Biopesticide Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World RNA Biopesticide Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World RNA Biopesticide Market Size Market Share by Type in 2025
Figure 31. PIP
Figure 32. Non-PIP
Figure 33. World RNA Biopesticide Market Size Market Share by Type (2021-2032)
Figure 34. World RNA Biopesticide Market Size by Target Organism, (USD Million), 2021 & 2025 & 2032
Figure 35. World RNA Biopesticide Market Size Market Share by Target Organism in 2025
Figure 36. Insect Pests
Figure 37. Nematodes and Mites
Figure 38. Pathogens
Figure 39. Other
Figure 40. World RNA Biopesticide Market Size Market Share by Target Organism (2021-2032)
Figure 41. World RNA Biopesticide Market Size by Crop, (USD Million), 2021 & 2025 & 2032
Figure 42. World RNA Biopesticide Market Size Market Share by Crop in 2025
Figure 43. Potatoes
Figure 44. Corn
Figure 45. Other
Figure 46. World RNA Biopesticide Market Size Market Share by Crop (2021-2032)
Figure 47. World RNA Biopesticide Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World RNA Biopesticide Market Size Market Share by Application in 2025
Figure 49. Farmland
Figure 50. Orchard
Figure 51. Other
Figure 52. World RNA Biopesticide Market Size Market Share by Application (2021-2032)
Figure 53. RNA Biopesticide Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source